Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Prostate Cancer
100%
Androgen Receptor
100%
Immunocompetent Cell
100%
Cell Density
100%
Protein Expression
87%
Hormone Therapy
50%
Clinical Trial
37%
Messenger RNA
37%
Immunotherapy
25%
Genetics
25%
Biological Marker
12%
T Cell
12%
Neoplasm
12%
Programmed Death-Ligand 1
12%
Regulatory T Cell
12%
Chimeric Antigen Receptor T-Cell
12%
Transcriptomics
12%
Immunohistochemistry
12%
Cancer Tissue
12%
Cell Composition
12%
Antibody-Drug Conjugate
12%
Androgen
12%
Immune Microenvironment
12%
Keyphrases
Prostate Cancer
100%
Androgen Signaling
100%
Immune Cell Counts
100%
B7 Homolog 3
100%
Racial Ancestry
100%
Protein Expression
36%
Clinical Trials
15%
African Ancestry
15%
Messenger RNA Expression
15%
Neoadjuvant
10%
Hormone Therapy
10%
Immunomodulatory Molecules
10%
T Cells
5%
Tumor
5%
Antibody-drug Conjugate
5%
Trial Design
5%
Programmed Death-ligand 1 (PD-L1)
5%
Black Women
5%
T Cell Targeting
5%
Primary Prostate Cancer
5%
Chimeric Antigen Receptor T Cells (CAR-T)
5%
Protein Level
5%
Clinical Grade
5%
Regulatory T (Treg) Cells
5%
Activity Score
5%
Cell Density
5%
Cancer Tissue
5%
Self-identification
5%
Ancestry Informative Markers
5%
B7 Family
5%
Biomarkers of Response
5%
Hormonal Therapy
5%
Lay Summary
5%
Immunohistochemical Tests
5%
Immune Microenvironment
5%
Diverse Populations
5%
Paired Analysis
5%
Racially Diverse
5%
Genetic Ancestry
5%
Transcriptomic Data
5%
Forkhead Box P3 (FOXP3)
5%
Adjuvant Hormonal Therapy
5%
Trial Interpretation
5%
Immune Cell Composition
5%
Biochemistry, Genetics and Molecular Biology
Protein Expression
100%
Immunocompetent Cell
100%
Cell Density
100%
Androgen Receptor
100%
Clinical Trial
42%
Messenger RNA
42%
T Cell
28%
Genetics
14%
PD-L1
14%
FOXP3
14%
Transcriptomics
14%
Conjugate
14%
Chimeric Antigen Receptor
14%
Cell Composition
14%
Regulatory T Cell
14%
Immune Microenvironment
14%
Genetic Ancestry
14%
Immunology and Microbiology
Protein Expression
100%
Immunocompetent Cell
100%
Cell Density
100%
Prostate
85%
Ribonucleic Acid
42%
Immunotherapy
28%
Regulatory T Cell
14%
Programmed Death-Ligand 1
14%
Transcriptomics
14%
FOXP3
14%
Chimeric Antigen Receptor T-Cell
14%
Antibody Drug Conjugate
14%
Cancer Tissue
14%
Cell Composition
14%
T Cell
14%
Pretreatment
14%
Immune Microenvironment
14%